US Stock MarketDetailed Quotes

LTRN Lantern Pharma

Watchlist
  • 3.660
  • -0.260-6.63%
Trading Jan 10 09:51 ET
39.47MMarket Cap-2.06P/E (TTM)

Lantern Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lantern Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 18, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 18, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Lantern Pharma Earnings Reports

  • Lantern Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:14 ET

  • Lantern Pharma | 8-K: Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates

    Nov 7, 2024 16:08 ET

  • Lantern Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:15 ET

  • Lantern Pharma | 8-K: Lantern Pharma Reports Second Quarter 2024 Financial Results and Business Updates

    Aug 8, 2024 16:15 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Dorian LPG
    LPG
    +4.24%
    New Fortress Energy
    NFE
    +1.67%
    SilverCrest Metals
    SILV
    +1.67%
    Lantheus
    LNTH
    +1.08%
    Collegium Pharmaceutical
    COLL
    +0.96%

    Unlock the Full List